Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sildenafil Citrate Orodispersible Tablets

Approval Number

国药准字H20243695

Company山东华铂凯盛生物科技有限公司

Registration Date

May 15, 2024

Drug Information

Generic Name

枸橼酸西地那非口崩片

Dosage Form

片剂

Strength

50mg（按C₂₂H₃₀N₆O₄S计）

Drug Type

化学药品

Registration Date

May 15, 2024

Company Information

Applicant Company

Company Name山东华铂凯盛生物科技有限公司

Company Address

山东省济南市高新区春兰路1177号银丰生物城B12号楼

Manufacturing Company

Company Name安徽泰恩康制药有限公司

Company Address

马鞍山市当涂工业园区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy